Tremelimumab antibody | AbD64586
Human anti Tremelimumab (Drug/Target Complex):HRP
- Product Type
- Monoclonal Antibody
- Clone
- AbD64586
- Isotype
- Fab antibody
- Specificity
- Tremelimumab
- Region
- DRUG/TARGET COMPLEX
Antibody Quality and Performance Guarantee
TZA0128P
A microtiter plate was coated overnight with various antigens at a concentration of 5 μg/mL. After washing and blocking with PBST + 5% BSA, detection was performed using HRP conjugated Human Anti-Tremelimumab (drug/target complex) Antibody, clone AbD64586pap (TZA0128P) at a concentration of 0.2 μg/mL in HISPEC Assay Diluent (BUF049A) and QuantaBlu fluorogenic peroxidase substrate.
A microtiter plate was coated overnight with CTLA-4, Tremelimumab, human IgGI kappa and lambda control at a concentration of 5 µg/mL. After washing and blocking with PBST + 5% BSA, the CTLA-4/tremelimumab complex was formed by adding 5 µg/mL tremelimumab to the wells coated with 5 µg/mL CTLA-4. Detection was performed using HRP conjugated Human Anti-Tremelimumab (Drug/Target Complex) Antibody, clone AbD64586pap (TZA0128P) titrated to the given concentrations in HISPEC Assay Diluent (BUF049A) followed by QuantaBlu fluorogenic peroxidase substrate. Data for CTLA-4/tremelimumab are shown as the mean of three measurements.
A microtiter plate was coated overnight with CTLA-4 at a concentration of 1 µg/mL. After washing and blocking with PBST + 5% BSA, 10% human serum was added spiked with increasing concentrations of tremelimumab. Detection was performed using HRP conjugated Human Anti-Tremelimumab (drug/target complex) Antibody, clone AbD64586pap (TZA128P) at a concentration of 0.5 µg/mL in HISPEC Assay Diluent (BUF049A) and QuantaBlu fluorogenic peroxidase substrate. Data are shown as the mean of three measurements.
Filter by Application:
E Reset| Human Anti-Tremelimumab (Drug/Target Complex) Antibody, clone AbD54142 specifically recognizes the antibody drug tremelimumab when in complex with its target, cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). It does not recognize free tremelimumab nor unbound CTLA-4. The monovalent Fab format of this antibody, clone AbD64586ad (TZA0128) is tagged with a SpyTag2 at the C-terminus of the Fab heavy chain, enabling the user to couple it to a SpyCatcher reagent for conversion to alternative formats in less than one hour. This antibody is also available as a bivalent Fab antibody pre-coupled to the HRP-conjugated BiSpyCatcher2 (TZC002P) under product code TZA0128P for direct detection of the Tremelimumab/ CTLA-4 complex in bioanalysis assays. Clone AbD64586 can be used in pharmacokinetic (PK) antigen capture format assays to measure tremelimumab that has been captured via immobilized CTLA-4. It is ideal for bioanalytical assays to measure the level of drug or biosimilar in complex with the CTLA-4 target. Tremelimumab (trade name Imjudo) is a fully humanized monoclonal IgG2/kappa antibody with allotype IGHG2*01. It binds to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) to enhance T cell-mediated killing of tumours and reduces tumour growth. Tremelimumab in combination with durvalumab and platinum-based chemo-therapy is indicated for the first-line treatment of adults with metastatic non-small cell lung cancer (NSCLC) with no sensitising EGFR mutations or ALK positive mutations. View a summary of all anti-tremelimumab antibodies |
- Product Form
- A bivalent human recombinant Fab (lambda light chain) generated by coupling of the monovalent SpyTagged Fab TZA0128 with a HRP conjugated BiSpyCatcher version 2 (TZC002P). The coupled antibody has two DYKDDDDK tags and three His6-tags. It contains SpyTag3 peptide (BLP086) in 5-fold molar excess to block any unreacted Catcher sites. This antibody is supplied as a liquid.
- Preparation
- Metal chelate affinity chromatography
- Source
- E.coli
- Buffer Solution
- Phosphate buffered saline
- Preservative Stabilisers
- 0.0095% MIT
- Immunogen
- CTLA-4/Tremelimumab complex
- Affinity
- The monovalent intrinsic affinity of AbD64586pap was measured as KD = 23 nM by real time, label free molecular interaction analysis on immobilized human CTLA-4/tremelimumab complex.
- Approx. Protein Concentrations
- Antibody concentration 0.5 mg/ml
- Regulatory
- For research purposes only
- Guarantee
- 12 months from date of despatch
- Acknowledgements
- This product and/or its use is covered by claims of U.S. patents, and/or pending U.S. and non-U.S. patent applications owned by or under license to Bio-Rad Laboratories, Inc. See bio-rad.com/en-us/trademarks for details.
His-tag is a registered trademark of EMD Biosciences.
Imjudo is a trademark of Pfizer a now investigated by MedImmune (AstraZeneca). - Licensed Use
- For in vitro research purposes only, unless otherwise specified in writing by Bio-Rad.
This product is shipped frozen.
When ready to use, thaw and aliquot the sample as needed. Store aliquots at -70°C, if available, otherwise store at -20°C. It is not recommended to keep aliquots at 4°C for more than one week.
When ready to use, thaw and aliquot the sample as needed. Store aliquots at -70°C, if available, otherwise store at -20°C. It is not recommended to keep aliquots at 4°C for more than one week.
This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit the antibody protocols page.
| Application Name | Verified | Min Dilution | Max Dilution |
|---|---|---|---|
| ELISA |  |
Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using appropriate negative/positive controls.
- Technical Advice
- Recommended protocols for coupling a Fab antibody with a SpyTag to a SpyCatcher can be found at SpyTag and SpyCatcher Products, and further information about HuCAL recombinant antibody technology can be found in the HuCAL Antibodies Technical Manual
- ELISA
- Clone AbD64586pap may be used in a direct ELISA to detect the human CTLA-4/Tremelimumab complex or to detect tremelimumab bound to immobilized human CTLA-4.
Protocol: PK antigen capture ELISA
| Description | Product Code | Applications | Pack Size | List Price | Your Price | Quantity | |
|---|---|---|---|---|---|---|---|
| Hispec Assay Diluent | BUF049A | E IY | 50 ml | Log in | |||
| List Price | Your Price | ||||||
| Log in | |||||||
| Description | Hispec Assay Diluent | ||||||
| Human anti Tremelimumab | TZA0126 | E | 0.1 mg |
|
Log in | ||
| List Price | Your Price | ||||||
|
|
Log in | ||||||
| Description | Human anti Tremelimumab | ||||||
| Human anti Tremelimumab | TZA0127 | E | 0.1 mg |
|
Log in | ||
| List Price | Your Price | ||||||
|
|
Log in | ||||||
| Description | Human anti Tremelimumab | ||||||
| Human anti Tremelimumab:HRP | TZA0127P | E | 0.1 mg |
|
Log in | ||
| List Price | Your Price | ||||||
|
|
Log in | ||||||
| Description | Human anti Tremelimumab:HRP | ||||||
| Human anti Tremelimumab (Drug/Target Complex) | TZA0128 | E | 0.1 mg |
|
Log in | ||
| List Price | Your Price | ||||||
|
|
Log in | ||||||
| Description | Human anti Tremelimumab (Drug/Target Complex) | ||||||
- Synonyms
- Imjudo
TZA0128P
172656
If you cannot find the batch/lot you are looking for please contact our technical support team for assistance.
View more products with Tremelimumab specificity
Please Note: All Products are "FOR RESEARCH PURPOSES ONLY"
Always be the first to know.
When we launch new products and resources to help you achieve more in the lab.
Yes, sign me up
